Julie C. Holder

6.6k total citations · 1 hit paper
32 papers, 3.3k citations indexed

About

Julie C. Holder is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Julie C. Holder has authored 32 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Physiology. Recurrent topics in Julie C. Holder's work include Peroxisome Proliferator-Activated Receptors (11 papers), Metabolism, Diabetes, and Cancer (7 papers) and Adipose Tissue and Metabolism (6 papers). Julie C. Holder is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (11 papers), Metabolism, Diabetes, and Cancer (7 papers) and Adipose Tissue and Metabolism (6 papers). Julie C. Holder collaborates with scholars based in United Kingdom, United States and Australia. Julie C. Holder's co-authors include Gregory Murphy, Stephen A. Smith, Darren A.E. Cross, David Haigh, Stacey L. Corcoran, Neil Pearce, John Yates, Matthew P. Coghlan, Ainsley A. Culbert and Carolyn A. Lister and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Diabetes.

In The Last Decade

Julie C. Holder

32 papers receiving 3.3k citations

Hit Papers

Selective small molecule inhibitors of glycogen synthase ... 2000 2026 2008 2017 2000 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
    2000 771 citations Matthew P. Coghlan, Ainsley A. Culbert et al. Chemistry & Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie C. Holder United Kingdom 23 2.3k 761 507 363 300 32 3.3k
Balvin H.L. Chua United States 39 2.5k 1.1× 754 1.0× 364 0.7× 298 0.8× 345 1.1× 68 4.6k
Mark D. Leibowitz United States 24 2.7k 1.2× 690 0.9× 343 0.7× 433 1.2× 367 1.2× 36 3.3k
Eric Raspé Belgium 24 2.5k 1.1× 1.1k 1.4× 467 0.9× 320 0.9× 449 1.5× 47 3.7k
Akira Uruno Japan 33 2.1k 0.9× 582 0.8× 339 0.7× 576 1.6× 321 1.1× 85 3.4k
Takafumi Kohama Japan 28 3.1k 1.4× 523 0.7× 255 0.5× 256 0.7× 302 1.0× 56 4.2k
Miguel Bronfman Chile 29 2.1k 0.9× 957 1.3× 228 0.4× 239 0.7× 176 0.6× 52 3.0k
Masaya Tanno Japan 36 2.2k 1.0× 875 1.1× 706 1.4× 465 1.3× 188 0.6× 122 4.6k
Larry Denner United States 35 1.8k 0.8× 550 0.7× 219 0.4× 366 1.0× 301 1.0× 71 3.6k
Noriyuki Shibata Japan 36 2.1k 0.9× 870 1.1× 403 0.8× 537 1.5× 509 1.7× 173 5.1k
Dipanjan Chanda South Korea 28 1.3k 0.6× 411 0.5× 478 0.9× 518 1.4× 214 0.7× 41 2.4k

Countries citing papers authored by Julie C. Holder

Since Specialization
Citations

This map shows the geographic impact of Julie C. Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie C. Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie C. Holder more than expected).

Fields of papers citing papers by Julie C. Holder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie C. Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie C. Holder. The network helps show where Julie C. Holder may publish in the future.

Co-authorship network of co-authors of Julie C. Holder

This figure shows the co-authorship network connecting the top 25 collaborators of Julie C. Holder. A scholar is included among the top collaborators of Julie C. Holder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie C. Holder. Julie C. Holder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellis, Scott, et al.. (2020). GT005, a gene therapy for the treatment of dry age-related macular degeneration (AMD). Investigative Ophthalmology & Visual Science. 61(7). 2295–2295. 19 indexed citations
2.
Lin, Hong, Haiyan Fang, Jamie Wang, et al.. (2015). Discovery of a novel 2,3,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinoline-1,4(6H)-dione series promoting neurogenesis of human neural progenitor cells. Bioorganic & Medicinal Chemistry Letters. 25(17). 3748–3753. 10 indexed citations
3.
Koh, Seong‐Ho, Anna C. Liang, Yōko Takahashi, et al.. (2015). Differential Effects of Isoxazole-9 on Neural Stem/Progenitor Cells, Oligodendrocyte Precursor Cells, and Endothelial Progenitor Cells. PLoS ONE. 10(9). e0138724–e0138724. 14 indexed citations
4.
Varley, Claire L., Lisa A. Kirkwood, Angela White, et al.. (2012). Differentiation-Associated Reprogramming of the Transforming Growth Factor β Receptor Pathway Establishes the Circuitry for Epithelial Autocrine/Paracrine Repair. PLoS ONE. 7(12). e51404–e51404. 6 indexed citations
5.
Owen, Bryn M., Alexandra Milona, Saskia W. C. van Mil, et al.. (2009). Intestinal Detoxification Limits the Activation of Hepatic Pregnane X Receptor by Lithocholic Acid. Drug Metabolism and Disposition. 38(1). 143–149. 24 indexed citations
6.
Varley, Claire L., et al.. (2008). FOXA1 and IRF-1 intermediary transcriptional regulators of PPARγ-induced urothelial cytodifferentiation. Cell Death and Differentiation. 16(1). 103–114. 57 indexed citations
7.
MacLaine, Nicola J., et al.. (2008). Sensitivity of Normal, Paramalignant, and Malignant Human Urothelial Cells to Inhibitors of the Epidermal Growth Factor Receptor Signaling Pathway. Molecular Cancer Research. 6(1). 53–63. 27 indexed citations
8.
Judson, Philip N., Paul Cooke, Nancy G. Doerrer, et al.. (2005). Towards the creation of an international toxicology information centre. Toxicology. 213(1-2). 117–128. 37 indexed citations
9.
Macanas-Pirard, Patricia, et al.. (2005). Glycogen Synthase Kinase-3 Mediates Acetaminophen-Induced Apoptosis in Human Hepatoma Cells. Journal of Pharmacology and Experimental Therapeutics. 313(2). 780–789. 34 indexed citations
10.
Pearce, Neil, Jonathan R.S. Arch, John C. Clapham, et al.. (2004). Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter. Metabolism. 53(10). 1322–1330. 90 indexed citations
11.
Schmuth, Matthias, Christopher M. Haqq, William Cairns, et al.. (2004). Peroxisome Proliferator-Activated Receptor (PPAR)-β/δ Stimulates Differentiation and Lipid Accumulation in Keratinocytes. Journal of Investigative Dermatology. 122(4). 971–983. 195 indexed citations
12.
Delaney, Jane, Mark P. Hodson, Hansa Thakkar, et al.. (2004). Tryptophan?NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation. Archives of Toxicology. 79(4). 208–223. 40 indexed citations
13.
14.
Murphy, Gregory & Julie C. Holder. (2000). PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends in Pharmacological Sciences. 21(12). 469–474. 318 indexed citations
15.
Coghlan, Matthew P., Ainsley A. Culbert, Darren A.E. Cross, et al.. (2000). Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chemistry & Biology. 7(10). 793–803. 771 indexed citations breakdown →
16.
Haigh, David, Helen Birrell, Derek R. Buckle, et al.. (1999). Non-thiazolidinedione antihyperglycaemic agents. Part 3: the effects of stereochemistry on the potency of α-methoxy-β-phenylpropanoic acids. Bioorganic & Medicinal Chemistry. 7(5). 821–830. 30 indexed citations
17.
Young, Paul, Derek R. Buckle, Barrie C. C. Cantello, et al.. (1998). Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γ. Journal of Pharmacology and Experimental Therapeutics. 284(2). 751–759. 90 indexed citations
18.
19.
20.
Holder, Julie C., et al.. (1990). The preferential uptake of very-low-density lipoprotein cholesteryl ester by rat liver in vivo. Biochemical Journal. 272(3). 735–741. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Balvin H.L. Chua Breakdown of academic impact, for papers by Mark D. Leibowitz Breakdown of academic impact, for papers by Eric Raspé Breakdown of academic impact, for papers by Akira Uruno Breakdown of academic impact, for papers by Takafumi Kohama Breakdown of academic impact, for papers by Miguel Bronfman Breakdown of academic impact, for papers by Masaya Tanno Breakdown of academic impact, for papers by Larry Denner Breakdown of academic impact, for papers by Noriyuki Shibata Breakdown of academic impact, for papers by Dipanjan Chanda
Rankless by CCL
2026